Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07294924

Prediction of REsponse to Depression Interventions (Accelerated rTMS) Using Clinical and TD-fNIRS Measurements

PREDICT-ACC: Prediction of REsponse to Depression Interventions (Accelerated rTMS) Using Clinical and TD-fNIRS Measurements

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Kernel · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

This observational, longitudinal, multi-cohort study aims to evaluate functional brain activity in adults undergoing treatment for Major Depressive Disorder (MDD) at participating clinical sites. A separate cohort of healthy adults will be enrolled as a control group. All data collected in this study are for research purposes only and will not influence clinical decision-making or treatment plans. This study will use TD-fNIRS to measure hemodynamic brain responses at rest and/or during tasks in patients receiving accelerated transcranial magnetic stimulation (TMS). Imaging will occur at multiple timepoints (pre-treatment, post-treatment, and follow-ups). Healthy control participants will complete similar measurements at one visit, with the option for a follow-up visit. The primary objectives are to assess feasibility, characterize brain activity patterns, and explore potential biomarkers associated with treatment response.

Conditions

Interventions

TypeNameDescription
OTHERfNIRS measurementKernel Flow is a non-invasive neuroimaging device that uses time-domain functional near-infrared spectroscopy (TD-fNIRS) to measure changes in cortical hemodynamics associated with brain activity.

Timeline

Start date
2025-12-15
Primary completion
2026-12-15
Completion
2026-12-15
First posted
2025-12-19
Last updated
2025-12-19

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT07294924. Inclusion in this directory is not an endorsement.